Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 1:43 pm Purchase | 2021-12-31 | 13G | IDEAYA BIOSCIENCES INC IDYA | Federated Hermes, Inc. FHI | 2,290,282 5.950% | 2,290,282 (New Position) | Filing History |
| 2022-02-14 1:40 pm Purchase | 2021-12-31 | 13G | DOMO INC CLASS B DOMO | Federated Hermes, Inc. FHI | 1,713,217 5.840% | 1,713,217 (New Position) | Filing History |
| 2022-02-14 1:38 pm Sale | 2021-12-31 | 13G | ALBIREO PHARMA INC ALBO | Federated Hermes, Inc. FHI | 2,358,624 12.230% | -2,922,223 (-55.34%) | Filing History |
| 2022-02-14 1:37 pm Purchase | 2021-12-31 | 13G | ANNEXON INC ANNX | Federated Hermes, Inc. FHI | 2,025,600 5.280% | 2,025,600 (New Position) | Filing History |
| 2022-02-14 1:35 pm Purchase | 2021-12-31 | 13G | AKOUOS INC AKUS | Federated Hermes, Inc. FHI | 2,498,442 7.240% | 178,960 (+7.72%) | Filing History |
| 2022-02-14 1:34 pm Purchase | 2021-12-31 | 13G | ANAPTYSBIO INC ANAB | Federated Hermes, Inc. FHI | 2,406,430 5.800% | 495,780 (+25.95%) | Filing History |
| 2022-02-14 1:31 pm Purchase | 2021-12-31 | 13G | ALBIREO PHARMA INC ALBO | Federated Hermes, Inc. FHI | 5,280,847 6.500% | 998,284 (+23.31%) | Filing History |
| 2022-02-14 1:29 pm Sale | 2021-12-31 | 13G | AMPHASTAR PHARMACEUTICALS INC AMPH | Federated Hermes, Inc. FHI | 3,464,335 7.240% | -6,685,665 (-65.87%) | Filing History |
| 2022-02-14 1:26 pm Purchase | 2021-12-31 | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | Federated Hermes, Inc. FHI | 830,986 6.620% | 830,986 (New Position) | Filing History |
| 2022-02-14 1:26 pm Unchanged | 2021-12-31 | 13G | ATYR PHARMA INC LIFE | Federated Hermes, Inc. FHI | 5,222,250 18.790% | 0 (Unchanged) | Filing History |
| 2022-02-14 1:24 pm Purchase | 2021-12-31 | 13G | OMEGA ALPHA SPAC OMEG | Federated Hermes, Inc. FHI | 1,000,000 6.990% | 1,000,000 (New Position) | Filing History |
| 2022-02-14 1:23 pm Unchanged | 2021-12-31 | 13G | BCLS ACQUISITION CORP BLSA | Federated Hermes, Inc. FHI | 1,000,000 6.730% | 0 (Unchanged) | Filing History |
| 2022-02-14 1:21 pm Purchase | 2021-12-31 | 13G | AMPHASTAR PHARMACEUTICALS INC AMPH | Federated Hermes, Inc. FHI | 10,150,000 7.260% | 3,150,000 (+45.00%) | Filing History |
| 2022-02-14 1:19 pm Purchase | 2021-12-31 | 13G | CONTRAFECT CORP CFRX | Federated Hermes, Inc. FHI | 91,215 18.550% | 25,000 (+37.76%) | Filing History |
| 2022-02-14 1:19 pm Purchase | 2021-12-31 | 13G | BRAZE, INC. CLASS A BRZE | Federated Hermes, Inc. FHI | 530,000 5.330% | 530,000 (New Position) | Filing History |
| 2022-02-14 1:17 pm Purchase | 2021-12-31 | 13G | DYNAVAX TECHNOLOGIES CORP COM DVAX | Federated Hermes, Inc. FHI | 16,782,838 13.920% | 4,261,038 (+34.03%) | Filing History |
| 2022-02-14 1:16 pm Purchase | 2021-12-31 | 13G | AVROBIO INC AVRO | Federated Hermes, Inc. FHI | 216,288 5.950% | 216,288 (New Position) | Filing History |
| 2022-02-14 1:14 pm Sale | 2021-12-31 | 13G | FREQUENCY THERAPEUTICS INC FREQ | Federated Hermes, Inc. FHI | 56,021 8.100% | -16,004 (-22.22%) | Filing History |
| 2022-02-14 1:12 pm Purchase | 2021-12-31 | 13G | AVIDITY BIOSCIENCES INC RNAM | Federated Hermes, Inc. FHI | 2,474,500 5.280% | 2,474,500 (New Position) | Filing History |
| 2022-02-14 1:12 pm Sale | 2021-12-31 | 13G | GAMIDA CELL LTD GMDAQ | Federated Hermes, Inc. FHI | 4,363,315 7.360% | -689,208 (-13.64%) | Filing History |